Mayo clinic researchers have developed a new class of “gamma-secretase modulator” (GSM) drugs that lower levels of the protein that forms the sticky clumps associated with Alzheimer’s, and boost levels of shorter pieces of the same protein, helping inhibit clump-formation of longer pieces.